Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03093155
Title Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Yale University

ovary epithelial cancer

peritoneum cancer

fallopian tube cancer


Bevacizumab + Ixabepilone


Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Smilow Cancer Hospital at Yale New Haven New Haven Connecticut 06510 United States Details
Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore Maryland 21201 United States Details
*Shaded cells indicate that there was no data available from for the field